Predict your next investment

INABATA company logo
HEALTHCARE | Pharmaceuticals / Drugs
inabata.fr

See what CB Insights has to offer

About INABATA

INABATA is a full service ingredients provider for pharmaceutical and cosmetic fields.

INABATA Headquarter Location

3 avenue Jeanne Garnerin

Wissous, 91320,

France

+33 (0) 1 60 49 17 10

Latest INABATA News

Inabata : Notice Concerning Announcement of Earnings Forecasts and Dividend Forecasts for the Fiscal Year Ending March 31, 2021

Aug 6, 2020

0 Message : August 6, 2020 Representative: Katsutaro Inabata, Director, President (Stock code: 8098, First Section of the Tokyo Stock Exchange) Inquiries: Year Ending March 31, 2021 Inabata & Co., Ltd. (the "Company") hereby gives consolidated earnings forecasts and dividend forecasts for the fiscal year ending March 31, 2021, which were undetermined in the "Summary of Consolidated Financial Results for the Year Ended March 31, 2020 (Based on Japanese GAAP)" announced on May 22, 2020 as follows. 1. Consolidated earnings forecasts (1) Consolidated earnings forecasts for the six months of the fiscal year ending March 31, 2021 (April 1, 2020 to September 30, 2020) Net sales September 30, 2019 Consolidated earnings forecasts for the fiscal year ending March 31, 2021 (April 1, 2020 to March 31, 2021) Net sales (3) Reasons for Announcement At the time the "Summary of Consolidated Financial Results for the Year Ended March 31, 2020 (Based on Japanese GAAP)" was announced, it was difficult to reasonably estimate the impact of the spread of the novel coronavirus disease (COVID-19), and therefore, the consolidated earnings forecast for the fiscal year ending March 31, 2021 was not yet determined. However, as economic activity in Japan and overseas is gradually resuming, we hereby announce that we have calculated the consolidated earnings forecast based on the projections available at this time. With regard to the outlook for the future, although the impact of COVID-19 is different in each country in which we operate and its effects will linger during the fiscal year, there will be no sudden downturn in the economy as experienced in the first three months of the fiscal year, and we expect a gradual recovery in the economic environment in Japan and the rest of the world over the next few months up to the end of March, 2021. With no prospect of an end to COVID-19, we expect that the environment for individual businesses will continue to be challenging. For the full year, we expect the negative impact to be particularly significant in the Plastics and Chemicals by segments in the Automotive, etc. by fields and Southeast Asia by region. If it becomes necessary to revise the earnings forecast due to the impact of a re-emergence of COVID-19 looking forward, we will promptly disclose the information. 2. Dividend forecasts

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.